Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Pulmonary arterial hypertension

Not yet recruiting

Registered drug

Study of calcifediol treatment to improve vitamin D levels in adults with pulmonary arterial hypertension

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Alpha-Tocopherol

Contact Research Centre

Pulmonary arterial hypertension

Not yet recruiting

Investigational

Study of Empagliflozin to Improve Heart Function in Adults with Pulmonary Arterial Hypertension

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Empagliflozin

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

A Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:PF-07868489

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Registered drugNo placebo

Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Study on Macitentan for Children with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Hungary

Participants:0–17 years · Healthy volunteers
Substances:Macitentan

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Sotatercept for Patients with Pulmonary Arterial Hypertension

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:PF-07868489

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Registered drugNo placebo

Study of Sotatercept for People with Pulmonary Arterial Hypertension

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Registered drug

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Macitentan

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on Long-Term Safety and Effectiveness of Treprostinil Palmitil for Patients with Pulmonary Arterial Hypertension

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Treprostinil Palmitil

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Find therapies in clinical trials near you – page 2

38 trials match your criteria

Pulmonary arterial hypertension

Study of calcifediol treatment to improve vitamin D levels in adults with pulmonary arterial hypertension

Pulmonary arterial hypertension

Study of Empagliflozin to Improve Heart Function in Adults with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension

A Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial

Pulmonary arterial hypertension

Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

Pulmonary arterial hypertension

Study on Macitentan for Children with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension

Study on the Safety and Tolerability of Sotatercept for Patients with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension

Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension

Study of Sotatercept for People with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension

Study of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality

Pulmonary arterial hypertension

Study on Long-Term Safety and Effectiveness of Treprostinil Palmitil for Patients with Pulmonary Arterial Hypertension

Pulmonary arterial hypertension

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.